Eye Care Market Overview in Netherlands

• Publication date: June 2010

Sales of eye care totalled Euros 1.4 million in 2009, lower performance than the previous year due to the low activity in terms of new product development. More Dutch people are becoming aware of OTC eye care by seeing the products on open shelves at drugstores, contributing to rising curiosity. However, the interest has not grown to the extent of boosting value growth. Euromonitor International's Eye Care Products in Netherlands report of...

Sales of eye care totalled Euros 1.4 million in 2009, lower performance than the previous year due to the low activity in terms of new product development. More Dutch people are becoming aware of OTC eye care by seeing the products on open shelves at drugstores, contributing to rising curiosity. However, the interest has not grown to the extent of boosting value growth.

Euromonitor International's Eye Care Products in Netherlands report offers a comprehensive guide to the size and shape of the industry at a national level. It provides the latest retail sales data from 2005 to 2009 , allowing you to identify the segments driving growth. Projections to 2014 illustrate how the industry is set to change.

Product coverage: Allergy Eye Care, Antibiotic Eye Care, Standard Eye Care

Data coverage: indsutry size (historic and projections ), market shares , brand shares and distribution channel figures .

Reasons to Buy This Report
* Gain in-depth understanding of the Consumer Health market ;
* Identify areas of growth and understand key dynamics ;
* Get a full overview of the competitive landscape , the industry ’s major players and leading brands;
* Anticipate market change with 5 year forecasts .

Euromonitor International has over 30 years experience of publishing industry research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Drug And Medication Industry in Netherlands

Eye Care in the Netherlands

June 2010
List of Contents and Tables
Executive Summary
Good Performance Sustained With Trends Towards Prevention and Faster Relief
Sports Nutrition Rises Fastest From A Small Base
Multinationals Focus on Innovations Amid the Strength of Private Label
Drugstores and the Internet Remain the Most Dynamic Channels
Steady Prospects Driven by Product Extensions Addressing Lifestyle Changes
Key Trends and Developments
Recession Poses A Threat To Consumer Health Market
Product Switches Important in Driving Growth
Consumers Increasingly Go for Prevention
More Relaxed Regulation on Distribution of OTC Products
Swine Flu Fears Lead To Consumers Adopting More Cautious Approach
Market Indicators
Data table 1 Consumer Expenditure on Health Goods and Medical Services from 2004 to 2009
Data table 2 Life Expectancy at Birth from 2004 to 2009
Market Data
Data table 3 Sales of Consumer Health by Segment : Value from 2004 to 2009
Data table 4 Sales of Consumer Health by Segment : % Value Growth from 2004 to 2009
Data table 5 Consumer Health Market Shares by Value from 2005 to 2009
Data table 6 Consumer Health Brand Shares by Value from 2006 to 2009
Data table 7 Penetration of Private Label by Segment from 2004 to 2009
Data table 8 Sales of Consumer Health by Distribution Format: % Analysis from 2004 to 2009
Data table 9 Sales of Consumer Health by Segment and Distribution Format: % Analysis 2009
Data table 10 Projection Sales of Consumer Health by Segment : Value from 2009 to 2014
Data table 11 Projection Sales of Consumer Health by Segment : % Value Growth from 2009 to 2014
Appendix
OTC Registration and Classification
Distribution
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Summary 1 Consumer Health Switches from 2007 to 2009
Definitions
Summary 2 Research Sources
Chefaro International BV
Strategic Direction
Key Facts
Summary 3 Chefaro International BV: Key Facts
Company Background
Production
Competitive Positioning
Summary 4 Chefaro International BV: Competitive Position 2009
Galvastore BV
Strategic Direction
Key Facts
Summary 5 Galvastore BV: Key Facts
Summary 6 Galvastore BV: Operational Indicators
Company Background
Production
Competitive Positioning
Imgroma BV
Strategic Direction
Key Facts
Summary 7 Imgroma BV: Key Facts
Summary 8 Imgroma BV: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 9 Imgroma BV: Competitive Position 2009
Pharma Nord BV
Strategic Direction
Key Facts
Summary 10 Pharma Nord BV: Key Facts
Summary 11 Pharma Nord BV: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 12 Pharma Nord BV: Competitive Position 2009
Springfield Nutraceuticals
Strategic Direction
Key Facts
Summary 13 Springfield Nutraceuticals BV: Key Facts
Company Background
Competitive Positioning
Summary 14 Springfield Nutraceuticals BV: Competitive Position 2009
Trends
Category Data
Data table 12 Sales of Eye Care by Subsector: Value from 2004 to 2009
Data table 13 Sales of Eye Care by Subsector: % Value Growth from 2004 to 2009
Data table 14 Standard Eye Care by Type: % Value Breakdown from 2007 to 2009
Data table 15 Eye Care Market Shares by Value from 2005 to 2009
Data table 16 Eye Care Brand Shares by Value from 2006 to 2009
Data table 17 Projection Sales of Eye Care by Subsector: Value from 2009 to 2014
Data table 18 Projection Sales of Eye Care by Subsector: % Value Growth from 2009 to 2014

Drug and Medication in Netherlands

Netherlands Vaccine Exports, Us$mn, % Y-o-y

• $ 250
• Industry data
• January 2013

Yearly, From 2003 To 2010
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI

• Industries : Drug and Medication
• Countries : Netherlands

Netherlands Vaccine Exports, Eurmn

• $ 250
• Industry data
• January 2013

Yearly, From 2002 To 2010
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI

• Industries : Drug and Medication
• Countries : Netherlands

Netherlands Vaccine Exports, Eurmn, % Y-o-y

• $ 250
• Industry data
• January 2013

Yearly, From 2003 To 2010
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI

• Industries : Drug and Medication
• Countries : Netherlands

Netherlands Vaccine Imports, Us$mn, % Y-o-y

• $ 250
• Industry data
• January 2013

Yearly, From 2003 To 2010
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI

• Industries : Drug and Medication
• Countries : Netherlands

Netherlands Vaccine Imports, Eurmn

• $ 250
• Industry data
• January 2013

Yearly, From 2002 To 2010
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI

• Industries : Drug and Medication
• Countries : Netherlands